Science to practice: Highly shifted proton MR imaging - A shift toward better cell tracking?

Radiology

Volumn 272, Issue 3, 2014, Pages 615-617

  Bulte, Jeff W M ^a   Morgan, Russell H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL TRACKING; FEMALE; FIBROSARCOMA; GRANULOMA; HUMANS; IMAGE ENHANCEMENT; MACROPHAGES; MAGNETIC RESONANCE IMAGING; QUATERNARY AMMONIUM COMPOUNDS;

EID: 84906847713     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14141410     Document Type: Article

References (7)

1. Ahrens ET, Bulte JW. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 2013;13(10):755-763.
2. Schmidt R, Nippe N, Strobel K, et al. Highly shifted proton MR imaging: cell tracking by using direct detection of paramagnetic compounds. Radiology 2014;272(3):785-795.
3. Zhang S, Winter P, Wu K, Sherry AD. A novel europium(III)-based MRI contrast agent. J Am Chem Soc 2001;123(7):1517-1518. (Pubitemid 32167350)
4. Bulte JW. Hot spot MRI emerges from the background. Nat Biotechnol 2005;23(8):945-946. (Pubitemid 41114026)
5. Bulte JWM. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 2009;193(2):314-325.
6. Partlow KC, Chen J, Brant JA, et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 2007;21(8):1647-1654. (Pubitemid 46855610)
7. Aime S, Carrera C, Delli Castelli D, Geninatti Crich S, Terreno E. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew Chem Int Ed Engl 2005;44(12):1813-1815.